Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery

NCT02595918 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

NIH

Sponsor class

Stopped Inadequate accrual rate

Conditions

Clear Cell Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
Stage I Renal Cell Cancer AJCC v6 and v7
Stage II Renal Cell Cancer AJCC v7
Stage III Renal Cell Cancer AJCC v7
Stage IV Renal Cell Cancer AJCC v7

Interventions

PROCEDURE: Metastasectomy
PROCEDURE: Nephrectomy
BIOLOGICAL: Nivolumab

Sponsor

National Cancer Institute (NCI)